Related Experiment Video
Updated: May 28, 2026
10:44
Influenza A Virus Studies in a Mouse Model of Infection
Published on: September 7, 2017
History and evolution of influenza vaccines
Journal of Preventive Medicine and Hygiene
|October 21, 2011
Summary
Influenza vaccines have evolved significantly since 1933, focusing on improved production, safety, and effectiveness. Ongoing research promises even more advanced influenza prevention tools.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Since the isolation of the influenza virus in 1933, substantial efforts have been dedicated to developing and refining influenza vaccines.
- Key areas of focus include enhancing vaccine production methods, ensuring rigorous quality control, and improving safety, tolerability, and immunogenicity.
Observation:
- The evolution of influenza vaccines reflects a continuous scientific endeavor to combat influenza virus infections.
- This progress encompasses advancements in manufacturing processes and stringent quality assurance protocols.
Findings:
- The paper reviews the historical development and key milestones in influenza vaccine technology.
- It highlights recent and emerging innovations poised to shape the future of influenza prevention.
Implications:
- Understanding the evolution of influenza vaccines is crucial for public health strategies.
- Continued innovation in vaccine development promises enhanced protection against influenza and its complications.
Related Concept Videos
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:51Vaccinations
Overview
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.